VitaSpring Biomedical Co. Ltd.
VSBC
$0.01
-$0.24-95.56%
OTC PK
| 07/31/2024 | 04/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.88% | -3.82% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.88% | -3.82% | |||
| Operating Income | -0.88% | 3.82% | |||
| Income Before Tax | -0.88% | 3.82% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -0.88% | 3.82% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -0.88% | 3.82% | |||
| EBIT | -0.88% | 3.82% | |||
| EBITDA | -0.89% | 3.29% | |||
| EPS Basic | -10.00% | 9.09% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | -10.00% | 9.09% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||